Principal Securities’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.21M Buy
12,642
+3,460
+38% +$1.88M 0.09% 209
2025
Q4
$5.32M Buy
9,182
+798
+10% +$451K 0.08% 232
2025
Q3
$4.07M Sell
8,384
-1,988
-19% -$925K 0.07% 270
2025
Q2
$4.21M Buy
10,372
+1,314
+15% +$549K 0.08% 250
2025
Q1
$4.71M Hold
9,058
0.11% 186
2024
Q4
$4.71M Buy
9,058
+766
+9% +$421K 0.11% 185
2024
Q3
$5.13M Buy
8,292
+1,982
+31% +$1.17M 0.12% 164
2024
Q2
$3.49M Buy
6,310
+1,860
+42% +$1.07M 0.1% 200
2024
Q1
$2.59M Buy
4,450
+812
+22% +$456K 0.08% 236
2023
Q4
$1.93M Buy
+3,638
New +$1.76M 0.07% 261

Other funds holding TMO

Principal Securities's TMO Position: Q1 2026 in Review

Principal Securities increased its Thermo Fisher Scientific (TMO) stake by 38% in Q1 2026, buying an estimated $1.88M and bringing the position to 12,642 shares worth $6.21M. The position accounts for 0.09% of the portfolio, ranked #209.

Principal Securities first reported a position in TMO in Q4 2023 and has held it in 10 quarters since. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Principal Securities held 12,642 shares of Thermo Fisher Scientific worth $6.21M as of Q1 2026.
  • Principal Securities bought 3,460 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.88M.
  • Thermo Fisher Scientific made up 0.09% of Principal Securities's portfolio in Q1 2026, its #209 holding.
  • Principal Securities first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 10 quarters since.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.